Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Innovation and Pearls in Teledermatology
Description
The talk argues that teledermatology and AI are reshaping dermatology and that dermatologists should actively lead this change rather than react to it. It reviews how telederm surged during the pandemic but then declined in routine use, with much of the remaining activity concentrated in academic centers and shifting toward asynchronous store-and-forward and e-consult models. The speaker highlights strong use cases, especially for psoriasis, emergency department rashes, rural and underserved communities, and regions with severe dermatologist shortages and long wait times. Telederm can improve access, reduce travel and cost barriers, and support better triage and treatment, including timely use of biologics for severe disease. The talk also covers billing and reimbursement updates, noting that telehealth extensions now run through 2027 and that coding guidance is available through professional resources. A key theme is that future growth in telederm will largely come from patient-centered direct-to-consumer models, some with AI integration, not just traditional office-based telemedicine. The speaker emphasizes a distributed care model, quality image capture, and the need to evolve business models so dermatologists can expand access while maintaining standards of care.
View moreConclusions
- Teledermatology is likely to keep growing, driven by patient demand, market forces, chronic skin disease burden, and AI-enabled platforms, so dermatologists need to engage with it rather than ignore it.
- For several dermatology use cases, especially psoriasis triage, asynchronous telederm and e-consults can achieve outcomes comparable to in-person care while improving efficiency.
- Teledermatology can meaningfully reduce access barriers for rural, Medicaid, and underserved patients by bypassing travel, time off work, and long wait times.
- The biggest limitations of teledermatology are often business-model and workflow issues rather than clinical feasibility, suggesting the need for better reimbursement and operational design.
- The future of dermatology is likely a distributed, hybrid network that combines in-person care, e-consults, remote supervision, and AI-assisted tools instead of relying on a single central provider bottleneck.
- AI is most useful in dermatology as a support tool for image capture, triage, and workflow improvement, but it should not replace dermatologist judgment.
- Direct-to-consumer teledermatology platforms are expanding rapidly and may compete with traditional practices, making transparency about quality, pricing, and oversight increasingly important.
- To remain relevant, dermatologists should help shape teledermatology systems so that access expands without sacrificing specialist standards or patient trust.
- Alghothani L, Jacks SK, Vander Horst A, Zirwas MJ. Archives of Dermatology. 2012;148(8):956-957. doi:10.1001/archdermatol.2012.804#10.1001/archdermatol.2012.804
- Direct-to-consumer teledermatology platforms may have inherent conflicts of interest. JAAD Online. October 2021#10.1016/j.jaad.2021.04.102